Gonzalo is an expert in company creation and innovation within the advanced therapies space. He is co-founder of three biotech companies focused on gene therapy and nanoparticle-based drug delivery: Ninevah Ltd, Nanobots SL, and CureAge Ltd. He was also involved in the early-stage management of an RNA therapeutics company, Aptadel SL.

Over the past five years, Gonzalo has held CSO and COO roles, gaining experience in R&D strategy, biotech management, fundraising, and licensing. He is currently the CEO of CureAge Therapeutics, a gene therapy company co-founded with Deep Science Ventures and the Children’s Tumor Foundation.

Gonzalo holds a PhD in Molecular Biology and has completed executive education at ESADE Business School.